ENTRY       D10538                      Drug
NAME        Nonacog gamma (INN);
            Nonacog gamma (genetical recombination) (JAN);
            Rixubis (TN)
SEQUENCE    YNSGKLXXFV QGNLXRXCMX XKCSFXXARX VFXNTXRTTX FWKQYVDGDQ CESNPCLNGG
            SCKDDINSYE CWCPFGFEGK NCELDVTCNI KNGRCEQFCK NSADNKVVCS CTEGYRLAEN
            QKSCEPAVPF PCGRVSVSQT SKLTRAEAVF PDVDYVNSTE AETILDNITQ STQSFNDFTR
            VVGGEDAKPG QFPWQVVLNG KVDAFCGGSI VNEKWIVTAA HCVETGVKIT VVAGEHNIEE
            TEHTEQKRNV IRIIPHHNYN AAINKYNHDI ALLELDEPLV LNSYVTPICI ADKEYTNIFL
            KFGSGYVSGW GRVFHKGRSA LVLQYLRVPL VDRATCLRST KFTIYNNMFC AGFHEGGRDS
            CQGDSGGPHV TEVEGTSFLT GIISWGEECA MKGKYGIYTK VSRYVNWIKE KTKLT
            (Disulfide bridge: 18-23, 51-62, 56-71, 73-82, 88-99, 95-109, 111-124, 132-289, 206-222, 336-350, 361-389)
  TYPE      Peptide
CLASS       Blood modifier agent
             DG02016  Hemostatics
              DG02014  Blood coagulation accelerant
               DG02013  Blood coagulation factor
REMARK      ATC code: B02BD04
            Chemical structure group: DG00171
            Product (DG00171): D08797<JP/US> D08794<JP> D05201<JP> D10757<JP> D10770<JP>
EFFICACY    Bleeding suppressant, Replenisher (coagulation factor)
COMMENT     recombination blood-coagulation factor IX (synthetic human) [HSA:2158] [KO:K01321]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B02 ANTIHEMORRHAGICS
               B02B VITAMIN K AND OTHER HEMOSTATICS
                B02BD Blood coagulation factors
                 B02BD04 Coagulation factor IX
                  D10538  Nonacog gamma (INN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG02016  Hemostatics
               DG02014  Blood coagulation accelerant
                DG02013  Blood coagulation factor
                 DG00171  Blood coagulation factor IX
                  D10538  Nonacog gamma
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10538
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10538
            Drug groups [BR:br08330]
             Blood modifier agent
              DG02016  Hemostatics
               DG02014  Blood coagulation accelerant
                DG02013  Blood coagulation factor
                 DG00171  Blood coagulation factor IX
DBLINKS     PubChem: 254741500
///
